Works matching IS 15228517 AND DT 2024 AND VI 26 AND IP 12


Results: 26
    1
    2

    Forthcoming Meetings.

    Published in:
    Neuro-Oncology, 2024, v. 26, n. 12, p. 2399, doi. 10.1093/neuonc/noae212
    Publication type:
    Article
    3
    5
    7
    8
    9
    10

    Intracranial administration of anti-PD-1 and anti-CTLA-4 immune checkpoint-blocking monoclonal antibodies in patients with recurrent high-grade glioma.

    Published in:
    Neuro-Oncology, 2024, v. 26, n. 12, p. 2208, doi. 10.1093/neuonc/noae177
    By:
    • Duerinck, Johnny;
    • Lescrauwaet, Louise;
    • Dirven, Iris;
    • Del'haye, Jacomi;
    • Stevens, Latoya;
    • Geeraerts, Xenia;
    • Vaeyens, Freya;
    • Geens, Wietse;
    • Brock, Stefanie;
    • Vanbinst, Anne-Marie;
    • Everaert, Hendrik;
    • Caljon, Ben;
    • Bruneau, Michaël;
    • Lebrun, Laetitia;
    • Salmon, Isabelle;
    • Kockx, Marc;
    • Tuyaerts, Sandra;
    • Neyns, Bart
    Publication type:
    Article
    12
    13

    RNA splicing as a biomarker and phenotypic driver of meningioma DNA-methylation groups.

    Published in:
    Neuro-Oncology, 2024, v. 26, n. 12, p. 2222, doi. 10.1093/neuonc/noae150
    By:
    • Leclair, Nathan K;
    • Choudury, Abrar;
    • Chen, William C;
    • Magill, Stephen T;
    • McCortney, Kathleen;
    • Horbinski, Craig M;
    • Chen, Zhenhong;
    • Goldschmidt, Ezequiel;
    • Eaton, Charlotte D;
    • Bulsara, Ketan R;
    • Bi, Wenya Linda;
    • Patel, Akash J;
    • Sahm, Felix;
    • Raleigh, David;
    • Anczukow, Olga
    Publication type:
    Article
    14

    Defining neuroblastoma: From origin to precision medicine.

    Published in:
    Neuro-Oncology, 2024, v. 26, n. 12, p. 2174, doi. 10.1093/neuonc/noae152
    By:
    • Sainero-Alcolado, Lourdes;
    • Bexelius, Tomas Sjöberg;
    • Santopolo, Giuseppe;
    • Yuan, Ye;
    • Liaño-Pons, Judit;
    • Arsenian-Henriksson, Marie
    Publication type:
    Article
    15
    16
    17

    A comparative analysis of IDH-mutant glioma in pediatric, young adult, and older adult patients.

    Published in:
    Neuro-Oncology, 2024, v. 26, n. 12, p. 2364, doi. 10.1093/neuonc/noae142
    By:
    • Lim-Fat, Mary Jane;
    • Cotter, Jennifer A;
    • Touat, Mehdi;
    • Vogelzang, Jayne;
    • Sousa, Cecilia;
    • Pisano, Will;
    • Geduldig, Jack;
    • Bhave, Varun;
    • Driver, Joseph;
    • Kao, Pei-Chi;
    • McGovern, Alana;
    • Ma, Clement;
    • Margol, Ashley S;
    • Cole, Kristina;
    • Smith, Amy;
    • Goldman, Stewart;
    • Kaneva, Kristiyana;
    • Truong, AiLien;
    • Nazemi, Kellie J;
    • Wood, Matthew D
    Publication type:
    Article
    18
    19

    Immune landscape of isocitrate dehydrogenase-stratified primary and recurrent human gliomas.

    Published in:
    Neuro-Oncology, 2024, v. 26, n. 12, p. 2239, doi. 10.1093/neuonc/noae139
    By:
    • Gupta, Pravesh;
    • Dang, Minghao;
    • Oberai, Shivangi;
    • Migliozzi, Simona;
    • Trivedi, Rakesh;
    • Kumar, Gayatri;
    • Peshoff, Mekenzie;
    • Milam, Nancy;
    • Ahmed, Aml;
    • Bojja, Krishna;
    • Tran, Tuan M;
    • Gumin, Joy;
    • Kamiya-Matsuoka, Carlos;
    • Huse, Jason;
    • Cox, Kathryn;
    • Li, Jianzhuo;
    • Shehwana, Huma;
    • Sheth, Sameer A;
    • Saxon, Rodriguez;
    • Baohua, Sun
    Publication type:
    Article
    20
    21

    Osimertinib-induced DNA resistance mutations in cerebrospinal fluid of epidermal growth factor receptor-mutated non-small-cell lung carcinoma patients developing leptomeningeal metastases: Osimertinib Resistance Analysis-leptomeningeal metastases study.

    Published in:
    Neuro-Oncology, 2024, v. 26, n. 12, p. 2316, doi. 10.1093/neuonc/noae138
    By:
    • Wel, J W Tijmen van der;
    • Boelens, Mirjam C;
    • Jebbink, Merel;
    • Smulders, Sietske A;
    • Maas, Klaartje W;
    • Luitse, Merel J A;
    • Compter, Annette;
    • Boltjes, Robin P B;
    • Sol, Nik;
    • Monkhorst, Kim;
    • van den Broek, Daan;
    • Smit, Egbert F;
    • Langen, Adrianus J de;
    • Brandsma, Dieta
    Publication type:
    Article
    22
    23

    SNO-EANO-EURACAN consensus on management of pineal parenchymal tumors.

    Published in:
    Neuro-Oncology, 2024, v. 26, n. 12, p. 2159, doi. 10.1093/neuonc/noae128
    By:
    • Liu, Anthony P Y;
    • Li, Bryan K;
    • Vasiljevic, Alexandre;
    • Dewan, Michael C;
    • Tamrazi, Benita;
    • Ertl-Wagner, Birgit;
    • Hansford, Jordan R;
    • Pfaff, Elke;
    • Mynarek, Martin;
    • Ng, Ho-Keung;
    • Tsang, Derek S;
    • Gottardo, Nicholas G;
    • Gajjar, Amar;
    • Bouffet, Eric;
    • Dufour, Christelle;
    • Pizer, Barry;
    • Schiff, David;
    • Jenkinson, Michael D;
    • Lombardi, Giuseppe;
    • Wen, Patrick Y
    Publication type:
    Article
    24

    Risk of new tumor, carotid stenosis, and stroke after stereotactic radiosurgery for pituitary tumor: A multicenter study of 2254 patients with imaging follow-up.

    Published in:
    Neuro-Oncology, 2024, v. 26, n. 12, p. 2328, doi. 10.1093/neuonc/noae133
    By:
    • Dumot, Chloe;
    • Mantziaris, Georgios;
    • Dayawansa, Sam;
    • Brantley, Carson;
    • Lee, Cheng-Chia;
    • Yang, Huai-Che;
    • Peker, Selcuk;
    • Samanci, Yavuz;
    • Mathieu, David;
    • Tourigny, Jean-Nicolas;
    • Moreno, Nuria Martinez;
    • Alvarez, Roberto Martinez;
    • Chytka, Thomas;
    • Liscak, Roman;
    • Speckter, Herwin;
    • Lazo, Erwin;
    • Brito, Anderson;
    • Picozzi, Piero;
    • Franzini, Andrea;
    • Alzate, Juan
    Publication type:
    Article
    25

    Safety and efficacy of selumetinib in pediatric and adult patients with neurofibromatosis type 1 and plexiform neurofibroma.

    Published in:
    Neuro-Oncology, 2024, v. 26, n. 12, p. 2352, doi. 10.1093/neuonc/noae121
    By:
    • Kim, Hyery;
    • Yoon, Hee Mang;
    • Kim, Eun Key;
    • Ra, Young Shin;
    • Kim, Hyo-Won;
    • Yum, Mi-Sun;
    • Kim, Min-Jee;
    • Baek, Jae Suk;
    • Sung, Yu Sub;
    • Lee, Sang Min;
    • Lim, Hyeong-Seok;
    • Lee, Byung Joo;
    • Lim, Hyun Taek;
    • Kim, Dohyung;
    • Yoon, Jihee;
    • Bae, Hyunwoo;
    • Hwang, Soojin;
    • Choi, Yun-Ha;
    • Kim, Kyung Ah;
    • Choi, In Hee
    Publication type:
    Article
    26

    Final outcome analysis from the phase II TUXEDO-1 trial of trastuzumab-deruxtecan in HER2-positive breast cancer patients with active brain metastases.

    Published in:
    Neuro-Oncology, 2024, v. 26, n. 12, p. 2305, doi. 10.1093/neuonc/noae123
    By:
    • Bartsch, Rupert;
    • Berghoff, Anna Sophie;
    • Furtner, Julia;
    • Marhold, Maximilian;
    • Bergen, Elisabeth Sophie;
    • Roider-Schur, Sophie;
    • Mair, Maximilian Johannes;
    • Starzer, Angelika Martina;
    • Forstner, Heidrun;
    • Rottenmanner, Beate;
    • Aretin, Marie-Bernadette;
    • Dieckmann, Karin;
    • Bago-Horvath, Zsuzsanna;
    • Haslacher, Helmuth;
    • Widhalm, Georg;
    • Ilhan-Mutlu, Aysegül;
    • Minichsdorfer, Christoph;
    • Fuereder, Thorsten;
    • Szekeres, Thomas;
    • Oehler, Leopold
    Publication type:
    Article